Australia: Boosting capital raisings for mid/small caps on the ASX

Corporate Update (Australia)
Last Updated: 6 July 2012
Article by Simon Davidson

Recently1, the ASX released draft proposals to enhance the capital raising environment for mid/small cap companies (MSC) currently listed on ASX2. A significant proposal is to enable MSCs to seek a 12-month mandate from shareholders to issue up to an additional 10% of the issued capital of the company without further approval. Given the size of most ASX-listed life sciences companies, this proposal is very significant for the sector.

This article briefly looks at:

  • What exactly is the proposal?
  • What are the benefits of the proposal?
  • Is there devil in the detail of the proposal?
  • Will the changes alter the capital raising process for MSCs in the life sciences sector?

What exactly is the proposal?

The proposed Listing Rule 7.1 A enables MSCs to seek shareholder approval to issue 10% of their issued capital, provided that the issue is not at a discount of greater than 25% of the market price. This placement capacity will be in addition to the 15% currently permitted under LR 7.1 without shareholder approval.

The maximum discount of 25% is to the average market price over the 15 previous actual trading days immediately prior to the issue. The method of calculating the discount is designed to avoid incongruous results arising out of nil trading days.

The mandate will be effective for 12 months (unless the company obtains shareholder approval under LR 11.1.2 or 11.2 to undertake a significant transaction) and remains valid even if the company's market capitalisation increases above AUD300 million during that 12 month period.

Additional disclosure obligations will apply in relation to both the notice of meeting seeking shareholder approval, and the disclosure notice at the time, of an issue under the new rule.

It should also be noted that the changes do not override LR 10.11 regarding placements to related parties which will still require shareholder approval before they can proceed.

What are the benefits of the proposal?

The proposal gives directors of a MSC the option of seeking a forward looking capital raising mandate. As a result, it allows directors flexibility to take advantage of capital raising opportunities as they arise on short notice without the need to obtain shareholder approval which effectively imposes a 35-45 day delay on any such opportunity. This is particularly important in the current market where market volatility means that opportunities need to be executed quickly.

The combined effect of LR 7.1 and 7.1A enabling the issue of up to 25% of issued capital at a 25% discount exceeds the parameters seen in comparable jurisdictions3. Further, given that 15% can be placed at any price, it provides MSCs with flexibility beyond that which they would achieve in comparable markets.

Is there devil in the detail of the proposal?

Beyond the 25/25 parameters, the detail needs to be considered. Firstly, the notice of meeting seeking approval for the mandate must include a statement of the purposes for which the securities may be issued. This requires a level of foresight for the directors which may clash with the benefit of having flexibility to move quickly (as noted above) to raise capital.

In addition, there is a voting exclusion which prevents a person who may participate or otherwise obtain a benefit from the proposed issue under the mandate from voting on the mandate. This may cause difficulty where substantial existing shareholders wish to support a future placement under the proposed new rule, but have already voted on the granting of the mandate.

On completion of an issue using the mandate, the company must make an announcement to ASX which includes a statement as to why the MSC used their capacity under the mandate rather than undertaking a pro rata or other issue. These statements will be scrutinised by shareholders in considering whether to renew such mandates in the future. Given the ability to raise funds with "low-doc" rights issues and share purchase plans, directors may find it difficult at times to justify the use of the mandate.

It is important to remember that the shareholder approval under the proposed new rule does not 'wipe the slate clean'. Rather, as with LR 7.1, a company must assess its placement capacity on a rolling 12 month basis, regardless of whether the relevant mandate has been obtained in the interim.

Given the greater restrictions which apply in relation to an issue under the proposed new rule (eg. the maximum discount), a company should consider prioritising an issue under a LR 7.1 A mandate over an issue under LR 7.1 in order to retain more flexible funding options moving forward.

Will the changes alter the capital raising process for MSCs in the life sciences sector?

Life sciences companies in Australia tend to follow a well-worn path. They list as MSCs with sufficient funding to take them through 18-24 months of further development, during which time they will seek to obtain licensing or other revenues to continue their development.

Retail investors who support IPOs in this sector see their investment as speculative - looking for the blue sky return - and understand the inherently risky nature of taking a life sciences product to market. As a result, they are generally not interested in follow on investment.

However the nature of life sciences business means that funding is required to take projects through various stages. If partnering funds are not available, this funding has to come from new investors. Accordingly, there is a reliance on placements ahead of rights issues and share purchase plans.

Given the time and effort required to raise funds through a placement, and the fact that MSCs by their very size are often looking to raise amounts which reflect a substantial portion of their market capitalisation, the changes proposed by the ASX are a welcome addition to the fund raising options available to MSCs in the sector.


1"Strengthening Australia's equity capital markets - ASX proposal and consultations", released by ASX Limited, 2 April 2012
2The ASX considers mid/small caps to be companies with a market capitalisation of AUD300m or less.
3The closest approximation is Toronto Stock Exchange which allows issues up to 25% of issued capital with a sliding scale maximum discount from 15-25% depending on the share price of the company in question. Hong Kong has a 20/20 limit, while Singapore only allows a 10% discount. In the UK, there is no limit on AIM, although UK companies at law have pre-emption rights built in which must be disapplied by shareholder resolution. IPC guidelines in the UK suggest 5/5 limit in any one year.

© DLA Piper

This publication is intended as a general overview and discussion of the subjects dealt with. It is not intended to be, and should not used as, a substitute for taking legal advice in any specific situation. DLA Piper Australia will accept no responsibility for any actions taken or not taken on the basis of this publication.

DLA Piper Australia is part of DLA Piper, a global law firm, operating through various separate and distinct legal entities. For further information, please refer to

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.